Rocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting

  • Jonathan Schwartz,

Press/Media

Period14 Apr 2021

Media coverage

2

Media coverage

  • TitleRocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date14/04/21
    PersonsJonathan Schwartz,
  • TitleRocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date14/04/21
    URLwww.firstwordpharma.com/node/1818814
    PersonsJonathan Schwartz,